Michael Redman

Michael Redman

Chief Executive Officer at
Theratome Bio, Inc.
71 year
Health Technology
Commercial Services
Consumer Services

Profile

Michael T.
Redman
was the founder of Opexa Pharmaceuticals, Inc., founded in 2001, where the title held was Chief Executive Officer from 2001 to 2005.
Mr. Redman was the founder of Oncolix, Inc., founded in 2006, where the title held was Chief Executive Officer & Director.
Mr. Redman is currently Chief Executive Officer at Theratome Bio, Inc. Mr. Redman is currently Chief Executive Officer & Director at GreenJay Therapeutics, Inc., starting in 2022.
Former positions include President, Chief Executive Officer, CFO & Director at Advanced Environmental Petroleum Producers, Inc.; Chief Executive Officer at Botanix Pharmaceuticals Ltd.; Director at Oncolix, Inc. from 2006 to 2019; Principal at Wyeth LLC; Principal at Repros Therapeutics, Inc.; Principal at Aronex Pharmaceuticals, Inc.; Chief Operating Officer & Executive Vice President at Genprex, Inc. from 2020 to 2021; Member at Licensing Executives Society; and Principal at Biovail Pharmaceuticals LLC.
Education includes undergraduate studies at the University of Missouri and an MBA from the University of Phoenix.

Michael Redman active positions

CompaniesPositionStart
Chief Executive Officer -

Former positions of Michael Redman

CompaniesPositionEnd
GENPREX, INC. Chief Operating Officer 2021-10-14
ONCOLIX, INC. Chief Executive Officer -
Chief Executive Officer 2004-12-31
Corporate Officer/Principal -
Chief Executive Officer -
See the detail of Michael Redman's experience

Training of Michael Redman

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

26

1st degree connections

14

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies14

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Health Technology

Consumer Services

Health Technology

Consumer Services

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

  1. Stock Market
  2. Insiders
  3. Michael Redman